 |
Bahrain licences first MS oral drugBahrain has licensed the world’s first oral medication for Multiple Sclerosis (MS), a nervous system disease that affects the brain and spinal cord leading to symptoms such as visual disturbances and muscle weakness. The Bahrain Ministry o More… |
Wednesday 27 November 2024
